Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Ordu C., Selcuk N. A. , Erdogan E., Angin G., Gural Z. , Memis H., ...Daha Fazla

MEDICINE, cilt.93, sa.28, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier


The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).